Sort
17,054 grants matching “genome editing”
Developing CRISPR genome editing technology for Entamoeba
$197,125Upinder Singh · Stanford University · R21 · FY2021 · AI
Understanding the variability in nonsense-mediated RNA decay
$197,091Sujatha Jagannathan · University Of Colorado Denver · R35 · FY2023 · GM
Protein Chemistry
$196,980Ronald T Raines · Massachusetts Institute Of Technology · R35 · FY2024 · GM
Core 4 Sali Echeverria
$196,979Andrej Sali · University Of California, San Francisco · U54 · FY2023 · AI
KIR2DL2 Immune Checkpoint as Modulator of T-Cell Effector Function
$196,934Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
The ODC A allele as a driver and therapeutic target of aggressive prostate cancer in African American men
$196,934Jong Y Park · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA
Developing intrabody therapeutics for mitochondrial DNA heteroplasmy
$196,929Brett A Kaufman · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · HD
High-throughput identification of novel therapeutic targets in lung cancer from genes with altered mRNA splicing
$196,899Angela Norie Brooks · University Of California Santa Cruz · R21 · FY2019 · CA
Investigating virus-host interactions with prime editing and genetic code expansion
$196,875Michael D Vahey · Washington University · R21 · FY2022 · AI
Impact of ApoE in Novel Rat Models of Late-Onset AD
$196,875William E. Van Nostrand · University Of Rhode Island · R21 · FY2024 · AG
The role of acetylcholine signaling in the axonal wiring of cortical interneurons
$196,875Hiroki Taniguchi · Ohio State University · R21 · FY2023 · NS
Impact of actin binding protein Coronin 1C in the pathogenesis of Parkinson's disease
$196,750Birgitt Schuele · Stanford University · R21 · FY2023 · NS
Characterization of degranulation regulators in human mast cells
$196,750Stephen J Galli · Stanford University · R21 · FY2022 · AI
Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer
$196,745Nicholas James Brady · Weill Medical Coll Of Cornell Univ · K22 · FY2024 · CA
Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer
$196,745Nicholas James Brady · Weill Medical Coll Of Cornell Univ · K22 · FY2025 · CA
Animal Model Production Section
$196,704Stephen A Murray · Jackson Laboratory · U42 · FY2019 · OD
Transgenic and Chimeric Mouse Facility
$196,690Stephen Aaron Liebhaber · University Of Pennsylvania · P30 · FY2019 · CA
CAR mast cell for solid tumor
$196,646Xiaolei Su · Yale University · R21 · FY2025 · CA
Prader-Willi syndrome (PWS) gene-domain and AAV miniaturization for gene therapy
$196,579Robert D Nicholls · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · HD
Transgenic and Chimeric Mouse Facility
$196,501Stephen Aaron Liebhaber · University Of Pennsylvania · P30 · FY2020 · CA
Identifying Pathogenic Non-Coding Mutations in Rare Mendelian Disease
$196,489Gregory E Crawford · Duke University · R21 · FY2019 · HG
The Roles of EYS in photoreceptor health
$196,425Huaiyu Hu · Upstate Medical University · R21 · FY2021 · EY
IDD Models Core
$196,311John P Svaren · University Of Wisconsin-Madison · P50 · FY2024 · HD
Interrogating regulatory variants by multiplexed genome editing
$196,302Melissa Gymrek · University Of California, San Diego · R21 · FY2018 · HG
The role of lipid droplets in immunity to M. tuberculosis infection
$196,250Sarah A Stanley · University Of California Berkeley · R21 · FY2016 · AI